Randomized Phase II Study Evaluating The Tolerability Of Adjuvant Docetaxel-Based Chemotherapy For Completely Resected Stage IB-II Non-Small Cell Lung Cancer (NSCLC): Toledo Trial
Phase of Trial: Phase II
Latest Information Update: 26 May 2016
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms Toledo
- 24 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Nov 2008 1 Dec 2008 added as the planned end date, based on information from ClinicalTrials.gov.
- 04 Oct 2008 Interim results presented at the Annual Congress of the European Respiratory Society 2008.